The board of directors at Viridian Therapeutics has a history of experience in the pharmaceutical and biomedical industries, as well as a strong educational background. Three of the members have served on the board of directors for other pharmaceutical companies, and one is currently the Senior Vice President for Scientific Affairs and Investor Relations Officer at Trevena, Inc. All four members have degrees from prestigious universities, including Duke University and the University of California, San Diego.
View all